Clinical Trial Update: A Single Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of MYK-491 [Phase 1]

View source ↗

Summary

This Phase 1 single ascending dose study evaluated the safety, tolerability, pharmacokinetics and pharmacodynamics of MYK-491 in Dilated Cardiomyopathy, and the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy

Drugs mentioned

• MYK-491

Snippet

Sponsor: MyoKardia, Inc. | Conditions: Dilated Cardiomyopathy | Phase 1 | Status: COMPLETED